Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise. A population-based ...
Jan 25, 2012
0
0
Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical ...
Jan 9, 2012
0
0
Since the National Cancer Institute developed the first guidelines on mammography screening over thirty years ago, advocacy and professional groups have developed guidelines focused on who should be screened, instead of communicating ...
Nov 21, 2011
0
0
New research is prompting a fresh look at the value of vitamin supplements, with some surprising results indicating that taking too many supplements of some could be harmful.
Oct 17, 2011
5
0
African Americans have higher rates of prostate cancer and are more likely to die from the disease than other groups in the United States, likely due to socioeconomic factors, healthcare access problems, and tumor biology. ...
Feb 18, 2021
0
1
The University of Hawaiʻi Cancer Center's Hawaiʻi Tumor Registry released updated cancer statistics in Hawaiʻi Cancer at a Glance, 2012-2016, which includes data on cancer incidence and mortality in the state of Hawaiʻi.
Jun 10, 2020
0
3
After differences in implementation and settings were accounted for, two important prostate cancer screening trials provide compatible evidence that screening reduces prostate cancer mortality. These findings suggest that ...
Sep 5, 2017
0
8
Cancer mortality rates vary considerably within the growing Hispanic population in the United States, with significant differences among the major Hispanic ethnic groups.
Feb 21, 2017
0
0
A substantial number of older patients with limited life expectancy continue to receive routine screenings for prostate, breast, cervical and colorectal cancer although the procedures are unlikely to benefit them.
Aug 18, 2014
1
0
A 30 percent reduction in mortality risk is one of the impressive results achieved in a global clinical drug trial for the treatment of prostate cancer. The full trial data are due to be presented today at one of the world´s ...
Jan 30, 2014
0
0
